Results 221 to 230 of about 325,858 (289)

The rise of 3D bioprinting advancements in modeling neurodegenerative diseases

open access: yesIbrain, EarlyView.
Modeling neurodegenerative diseases: 3D bioprinting as a strategy for replicating the complexity of brain architecture. Recent findings have demonstrated that 3D bioprinting platforms can be exploited to recreate the complex neural pattern, giving the possibility of controlling cell density and scaffold stiffness.
Lucia Iafrate, Gianluca Cidonio
wiley   +1 more source

Loss of aquaporin-4 impairs cerebrospinal fluid solute clearance through cerebrospinal fluid drainage pathways. [PDF]

open access: yesSci Rep
Kato D   +13 more
europepmc   +1 more source

Navigating the treatment landscape of Alzheimer's disease: Current strategies and future directions

open access: yesIbrain, EarlyView.
Alzheimer's disease treatment is evolving rapidly, with emerging strategies targeting multiple disease pathways. This graphical abstract highlights the shift from traditional therapies to innovative approaches that hold promise for improving outcomes.
Tapas Kumar Mohapatra   +4 more
wiley   +1 more source

Hydrocephalus and myelomeningocele; series and results

open access: yesCerebrospinal Fluid Research, 2005
Zamora J   +4 more
doaj   +1 more source

Nanotechnology in brain cancer treatment: The role of gold nanoparticles as therapeutic enhancers

open access: yesIbrain, EarlyView.
This review highlights the potential of gold nanoparticles (AuNPs) in overcoming the blood‐brain barrier (BBB) to improve brain tumor treatment. By enabling targeted drug delivery and enhancing therapies like radiotherapy, phototherapy, and chemotherapy, AuNPs offer a promising approach for safer, more effective treatments of glioblastoma and other ...
Simona Tarantino   +4 more
wiley   +1 more source

Distinct cerebrospinal fluid DNA methylation signatures linked to Alzheimer’s disease

open access: yes
Rados M   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy